Navigation Links
Sponsor of Presidential Health Care Forum Has a $4 Billion Conflict of Interest: Kucinich
Date:9/19/2007

AARP deal with private insurers raises serious questions

WASHINGTON, Sept. 19 /PRNewswire-USNewswire/ -- The sponsor of tomorrow night's Presidential forum in Iowa focused on health care reform has "a $4 billion vested interest in preserving the role of private, for-profit insurance companies in the health care industry," Ohio Congressman and Democratic Presidential candidate Dennis Kucinich said today.

According to published reports, the American Association of Retired Persons (AARP) "will net AARP $4.4 billion over seven years from the insurance giants United Healthcare and Aetna" with whom the organization signed agreements earlier this year. Under the AARP brand name, the organization will promote Aetna insurance policies to its members between the ages of 50 and 64 and United Healthcare policies for Medicare-eligible members.

Kucinich, the only Democratic candidate proposing a national, not-for-profit health insurance plan that would eliminate for-profit insurers from the health care system (HR 676), was specifically excluded from tomorrow's forum by AARP.

"It's clear that they didn't want me upsetting their multi-billion dollar applecart," Kucinich said. "The health care plans of the invited candidates preserve and promote the interests of for-profit insurance and pharmaceutical companies at the expense of tens of millions of everyday Americans who either can't afford coverage or are being over-charged for the inadequate coverage they struggle to afford."

Kucinich said AARP's sponsorship of the Presidential forum "is like having Haliburton or Blackwater sponsor a Presidential forum on doing away with no-bid government contracts to private contractors; or an oil company sponsoring a forum on reducing the world's dependence on oil."

Kucinich emphasized that he was not taking issue with the 38 million members of AARP. "Millions of trusting AARP members have bought Medicare-supplemental and prescription drug insuran
'/>"/>

SOURCE Kucinich for President 2008
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Clinicians Participating In the Pharmaceutical-Sponsored Trails Tend To Prescribe Their Drugs
2. Sponsor to Pull Measure Mandating HPV Vaccine
3. Republican Presidential Candidates Discuss Abortion, Stem Cells as Part of First Debate
4. Presidential Commission Wants Proper Care of Wounded Soldiers at Their Homes
5. Poor health care in Russia maybe causing Decline in its Population
6. Startling Expose – Physicians Often Have No Regular Source Of Health Car
7. Debate Rages over firing of HIV infected health care workers
8. Want a Healthy brew? Have some Tea!
9. Patient’s perception of health status helps in better recover
10. Antioxidants protect health tissue in people undergoing radiation therapy.
11. Sexual abuse affect health for a lifetime
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)...July 9 /PRNewswire/ -- leViv, Inc. (http://www.le... nutrition and lifestyle programs for,individual h.... The new,programs include 28-days of delicious, d...r 110 items in every order), online recipes, healt...urces, professional advice,news, health informati...
(Date:7/9/2008)... /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE...s to the global life,sciences markets, today annou...mited (AECL) with notice of arbitration proceeding...fulfill its contractual obligations,under its 2006...d if not,granted, seeking significant monetary dam...
(Date:7/9/2008)... adds to its unparalleled content on breastfeeding... professional articles on child, health, from alle...lking., BOULDER, Colo., July 9 /PRNewswire/ -- Br...verything for the New Mom, improves its already,un... doctor-reviewed,professional articles on infant, ...
(Date:7/9/2008)... DRE, Inc., a premier international surgical...mers that as much as $250,000 in medical equipment...lings. , Louisville, KY (...f 2008, in accordance with Tax Code Section 179, c...t bought in 2008. This could make 2008 an attracti...
Breaking Medicine News(10 mins):Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 2Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 3Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 2Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 3Health News:Breastfeeding.com Becomes a Premier Resource on Child Health 2Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2
...ced which has been found to have less side effects...mmunotherapy vaccines. //Antibodies against the al...nt encounters the allergen or infection these anti...o counteract the allergen which is an antigen. Co...
...n at University of California, San Francisco have ...innovative devices to first remove and then recons...ccess tumors. // Tumors which are present in the b...cult to operate. The neurosurgeon used a new tec...
...igration/Macrophage Inhibitory factor (MIF) which ...ultiple Sclerosis. This new pathway can be used in...in a way progression of Multiple Sclerosis is hind.... Multiple Sclerosis is an autoimmune disease wh...
...t tiagabine, a selective ?-aminobutyric acid (GABA... and next-morning alertness and performance in adu...mnia is characterized by difficulty initiating or ...sleep, which causes clinically significant distres...
Other Medicine News:Health News:Oral Edible vaccine for Allergy Vaccines 2Health News:Macrophage Inhibitory Factor Causes Multiple Sclerosis Progression 2
(Date:7/7/2008)...s scientific evidence supporting accuracy of, it...ajor international co...ly 7 /- Molecular,Biometrics, LLC, a ...el,clinical tools for applications in personalized... function in health and disease, presented data fr...
(Date:7/7/2008)...- Biopure Corporation,(Nasd...sions with the Food,and Drug Administration (FDA) ...r a new clinical trial of Hemopure(R) [hemoglobin ... proposed to study use of Hemopure,in patients suf...efuse,transfusion with blood components. Currently...
(Date:7/6/2008)...f Assay Submitted for FDA Clearance, SAN DIEGO, J...segment,of BD (Becton, Dickinson and Company) (NYS...D GeneOhm(TM) Cdiff molecular assay for the rapid ...nfection (CDI). It is the first CDI,diagnostic tes... one test,procedure. BD has also submitted this as...
(Date:7/3/2008)...Newswire-USNewswire/ -- All newborn infants,should...resent at birth,according to a new recommendation... recommendation and the accompanying summary of ev... Children whose hearing is impaired at birth, duri... with verbal and nonverbal communication and,socia...
Breaking Medicine Technology:Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 2Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 3Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 4Biopure Announces Meeting With FDA 2Biopure Announces Meeting With FDA 3BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 2BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 3Task Force Recommends Screening for Hearing Loss in All Newborns 2Task Force Recommends Screening for Hearing Loss in All Newborns 3Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 1Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 2Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 3Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 4Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 5Ovarian cancer risk not affected by alcohol and smoking but reduced by caffeine 9872 1Ovarian cancer risk not affected by alcohol and smoking but reduced by caffeine 9872 2Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 1Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 2Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 3Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 4Deli Chef Tri Bean Salad Recalled From Some Kroger Stores 9868 1
...Point Therapeutics, Inc.,(NASDAQ: POTP) today repo... at the 2007 Annual Meeting of the American,Associ...os Angeles,California, April 14-18, 2007. The AAC...es on talabostat,s novel mechanism of action., Add...follows: , Presentation Date and Time: Monday, Apr...
... - Ascenta Therapeutics,Inc. announced today that...ing compounds will be featured in three oral,prese...week,s 2007,Annual Meeting of the American Associa... Angeles, California April 14-18, 2007., Ascenta,s...t the,"High Impact Late-Breaking Research 1" sessi...
Other Medicine Technology:Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 2Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 3Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 4Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 5Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 6
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: